Over-Diagnosis and Breast Cancer Screening

Medicine and Dentistry

• Intraductal Carcinoma 100%
• Breast Cancer Screening 100%
• Overdiagnosis 100%
• Malignant Neoplasm 81%
• Screening 72%
• Neoplasm 45%
• Therapeutic Procedure 45%
• Lesion 27%
• Prevalence 27%
• Screening Test 27%
• Tumor Invasion 27%
• Mortality 27%
• Incidence 27%
• Diseases 18%
• Breast Cancer 18%
• Systemic Therapy 18%
• Micrometastasis 18%
• Gene 18%
• Survival 18%
• Patient 18%
• Death 18%
• Cancer Incidence 9%
• Phenotype 9%
• Toxicity 9%
• Disparity 9%
• Irradiation 9%
• Awareness 9%
• N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide 9%
• Exercise 9%
• Lifespan 9%
• Early Intervention 9%
• Tamoxifen 9%
• Gamma Urogastrone 9%
• Epidermal Growth Factor Receptor 2 9%
• Mastectomy 9%
• Breast Lesion 9%
• Invasive Carcinoma 9%
• Hormone Receptor 9%
• Enalapril Maleate 9%
• Growth 9%
• Incidental Finding 9%
• Lumpectomy 9%
• Analysis 9%
• Assay 9%
• Public Health 9%
• Breast 9%
• Character 9%
• Disease 9%
• Woman 9%
• Recognition 9%
• Cancer Types 9%
• Lung 9%
• Prognosis 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Intraductal Carcinoma 100%
• Malignant Neoplasm 90%
• Neoplasm 45%
• Prevalence 27%
• Mortality 27%
• Tumor Invasion 27%
• Incidence 27%
• Diseases 18%
• Micrometastasis 18%
• Survival 18%
• Death 18%
• Cancer Incidence 9%
• Toxicity 9%
• Tamoxifen 9%
• Irradiation 9%
• Prognosis 9%
• Hormone Receptor 9%
• Enalapril Maleate 9%
• Epidermal Growth Factor Receptor 2 9%
• N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide 9%
• Gamma Urogastrone 9%
• Invasive Carcinoma 9%
• Breast Lesion 9%

Neuroscience

• Metastasis 18%
• Gene 18%
• Phenotype 9%
• Epidermal Growth Factor Receptor 2 9%
• Tamoxifen 9%
• Hormone Receptor 9%
• Markov Models 9%
• Recognition 9%